Trxade Health Inc
General ticker "MEDS" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $10.1M
Trxade Health Inc follows the US Stock Market performance with the rate: 19.0%.
Estimated limits based on current volatility of 1.6%: low 6.94$, high 7.17$
Factors to consider:
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [3.29$, 13.09$]
- 2023-12-31 to 2024-12-30 estimated range: [1.90$, 7.28$]
Financial Metrics affecting the MEDS estimates:
- Negative: Operating Income to Revenue ratio of -0.19 <= 0.01
- Negative: Non-GAAP EPS of -6.15 <= 0.11
- Negative: Operating Cash Flow per share of -2.70 <= 0.22
- Negative: negative Net Income
- Negative: Industry Operating Cash Flow per share (median) of -0.25 <= 0.31
Short-term MEDS quotes
Long-term MEDS plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $17.12MM | $9.89MM | $11.45MM |
| Operating Expenses | $19.63MM | $15.18MM | $14.20MM |
| Operating Income | $-2.51MM | $-5.29MM | $-2.76MM |
| Non-Operating Income | $-0.03MM | $-0.02MM | $-1.15MM |
| Interest Expense | $0.03MM | $0.02MM | $0.34MM |
| R&D Expense | $0.66MM | $1.37MM | $1.16MM |
| Income(Loss) | $-2.54MM | $-5.32MM | $-3.91MM |
| Taxes | $0.00MM | $0.00MM | $0.40MM |
| Profit(Loss) | $-2.54MM | $-5.32MM | $-4.31MM |
| Stockholders Equity | $8.68MM | $3.77MM | $0.76MM |
| Assets | $9.79MM | $5.77MM | $3.71MM |
| Operating Cash Flow | $-2.21MM | $-2.57MM | $-1.53MM |
| Investing Cash Flow | $-0.04MM | $-0.02MM | $-0.43MM |
| Financing Cash Flow | $5.30MM | $-0.21MM | $-0.04MM |
| Earnings Per Share* | $-4.99 | $-7.58 | $-7.63 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.